|
1
|
Chen WQ, Zheng RS, Zhang SW, Zeng HM and
Zou XN: The incidences and mortalities of major cancers in China,
2010. Chin J Cancer. 33:402–405. 2014.PubMed/NCBI
|
|
2
|
Jiang C, Chen X, Alattar M, Wei J and Liu
H: MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis
of gastric cancer. Cancer Gene Ther. 22:291–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crone SG, Jacobsen A, Federspiel B,
Bardram L, Krogh A, Lund AH and Friis-Hansen L: microRNA-146a
inhibits G protein-coupled receptor-mediated activation of NF-κB by
targeting CARD10 and COPS8 in gastric cancer. Mol Cancer.
11:712012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carthew RW and Sontheimer EJ: Origins and
Mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao Y, Deng C, Lu W, Xiao J, Ma D, Guo M,
Recker RR, Gatalica Z, Wang Z and Xiao GG: let-7 microRNAs induce
tamoxifen sensitivity by downregulation of estrogen receptor α
signaling in breast cancer. Mol Med. 17:1233–1241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song Y, Xu Y, Wang Z, Chen Y, Yue Z, Gao
P, Xing C and Xu H: MicroRNA-148b suppresses cell growth by
targeting cholecystokinin-2 receptor in colorectal cancer. Int J
Cancer. 131:1042–1051. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang H, Yu WW, Wang LL and Peng Y:
miR-130a acts as a potential diagnostic biomarker and promotes
gastric cancer migration, invasion and proliferation by targeting
RUNX3. Oncol Rep. 34:1153–1161. 2015.PubMed/NCBI
|
|
11
|
Agaoglu Yaman F, Kovancilar M, Dizdar Y,
Darendeliler E, Holdenrieder S, Dalay N and Gezer U: Investigation
of miR-21, miR-141, and miR-221 in blood circulation of patients
with prostate cancer. Tumour Biol. 32:583–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ilan N, Elkin M and Vlodavsky I:
Regulation, function and clinical significance of heparanase in
cancer metastasis and angiogenesis. Int J Biochem Cell Biol.
38:2018–2039. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yingying X, Yong Z, Zhenning W, Xue Z, Li
J, Yang L and Huimian X: Role of heparanase-1 in gastric carcinoma
invasion. Asian Pac J Cancer Prev. 10:151–154. 2009.PubMed/NCBI
|
|
14
|
Wang Z, Xu H, Jiang L, Zhou X, Lu C and
Zhang X: Positive association of heparanase expression with tumor
invasion and lymphatic metastasis in gastric carcinoma. Mod Pathol.
18:205–211. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Sullivan PS, Goodman JC,
Gunaratne PH and Marchetti D: MicroRNA-1258 suppresses breast
cancer brain metastasis by targeting heparanase. Cancer Res.
71:645–654. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu H, Chen X, Gao W and Jiang G: The
expression of heparanase and microRNA-1258 in human non-small cell
lung cancer. Tumour Biol. 33:1327–1334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union Against Cancer (UICC)TNM Classification of
Malignant Tumours. 7th. Wiley-Blackwell; New York: pp. 117–126.
2010
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Zheng X, Shen C and Shi Y:
MicroRNA-203 suppresses cell proliferation and migration by
targeting BIRC5 and LASP1 in human triple-negative breast cancer
cells. J Exp Clin Cancer Res. 31:582012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang N, Liang H, Zhou Y, Wang C, Zhang S,
Pan Y, Wang Y, Yan X, Zhang J, Zhang CY, et al: miR-203 suppresses
the proliferation and migration and promotes the apoptosis of lung
cancer cells by targeting SRC. PLoS One. 9:e1055702014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiang Y, Song Y, Wang Z, Chen Y, Yue Z,
Xu H, Xing C and Liu Z: Aberrant expression of miR-203 and its
clinical significance in gastric and colorectal cancers. J
Gastrointest Surg. 15:63–70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu
HM, Zhang X, Jiang L, Xing CZ and Zhang Y: MicroRNA-148b is
frequently down-regulated in gastric cancer and acts as a tumor
suppressor by inhibiting cell proliferation. Mol Cancer. 10:12011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li HL, Gu J, Wu JJ, Ma CL, Yang YL, Wang
HP, Wang J, Wang Y, Chen C and Wu HY: Heparanase mRNA and protein
expression correlates with clinicopathologic features of gastric
cancer patients: A Meta- analysis. Asian Pac J Cancer Prev.
16:8653–8658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Xu S, Tan Q and Liu L: High
expression of heparanase-2 is an independent prognostic parameter
for favorable survival in gastric cancer patients. Cancer
Epidemiol. 37:1010–1013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma XM, Shen ZH, Liu ZY, Wang F, Hai L, Gao
LT and Wang HS: Heparanase promotes human gastric cancer cells
migration and invasion by increasing Src and p38 phosphorylation
expression. Int J Clin Exp Pathol. 7:5609–5621. 2014.PubMed/NCBI
|
|
27
|
Tang B, Xie R, Qin Y, Xiao YF, Yong X,
Zheng L, Dong H and Yang SM: Human telomerase reverse transcriptase
(hTERT) promotes gastric cancer invasion through cooperating with
c-Myc to upregulate heparanase expression. Oncotarget.
7:11364–11379. 2016.PubMed/NCBI
|
|
28
|
Yue Z, Song Y, Wang Z, Luo Y, Jiang L,
Xing L, Xu H and Zhang X: Association of heparanase gene (HPSE-1)
single nucleotide polymorphisms with gastric cancer. J Surg Oncol.
102:68–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li AL, Song YX, Wang ZN, Gao P, Miao Y,
Zhu JL, Yue ZY and Xu HM: Polymorphisms and a haplotype in
heparanase gene associations with the progression and prognosis of
gastric cancer in a northern Chinese population. PLoS One.
7:e302772012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dyrskjøt L, Ostenfeld MS, Bramsen JB,
Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL,
Andersen CL, Zieger K, et al: Genomic profiling of microRNAs in
bladder cancer: miR-129 is associated with poor outcome and
promotes cell death in vitro. Cancer Res. 69:4851–4860. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y
and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular
carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer
Res. 69:1135–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Strillacci A, Griffoni C, Sansone P,
Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G
and Tomasi V: MiR-101 downregulation is involved in
cyclooxygenase-2 overexpression in human colon cancer cells. Exp
Cell Res. 315:1439–1447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duursma AM, Kedde M, Schrier M, le Sage C
and Agami R: miR-148 targets human DNMT3b protein coding region.
RNA. 14:872–877. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R,
Sun Z and Zheng X: Downregulation of CCND1 and CDK6 by miR-34a
induces cell cycle arrest. FEBS Lett. 582:1564–1568. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takahashi Y, Forrest AR, Maeno E,
Hashimoto T, Daub CO and Yasuda J: MiR-107 and MiR-185 can induce
cell cycle arrest in human non small cell lung cancer cell lines.
PLoS One. 4:e66772009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu J, Qian J, Li C, Kwok L, Cheng F, Liu
P, Perdomo C, Kotton D, Vaziri C, Anderlind C, et al: miR-129
regulates cell proliferation by downregulating Cdk6 expression.
Cell Cycle. 9:1809–1818. 2010. View Article : Google Scholar : PubMed/NCBI
|
